Literature DB >> 3013936

Effects of the putative neutrophil-generated toxin, hypochlorous acid, on membrane permeability and transport systems of Escherichia coli.

J M Albrich, J H Gilbaugh, K B Callahan, J K Hurst.   

Abstract

Titrimetric addition of hypochlorous acid (HOCl) or chloramine (NH2Cl) to suspensions of Escherichia coli decreases their ability to accumulate 14C-labeled glutamine, proline, thiomethylgalactoside, and leucine in a manner that approximately coincides with loss of cell viability; quantitative differences in cellular response are observed with the two oxidants. Inhibition of beta-galactosidase activity in E. coli ML-35, a strain lacking functional lactose permease, is complex and also depends upon the identity of the oxidant. Membrane proton conductivities and glycerol permeabilities are unchanged by addition of HOCl or NH2Cl in excess of that required for inactivation. The combined results are interpreted to indicate that the locus of HOCl attack is the cell envelope, that HOCl inactivation does not occur by loss of membrane structural integrity, that loss of transport function can be identified with either selective oxidative inhibition of the transport proteins or loss of cellular metabolic energy, and that different mechanisms of inactivation may exist for HOCl and NH2Cl.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013936      PMCID: PMC329547          DOI: 10.1172/JCI112548

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  The inactivation of the transport mechanism for beta-galactosides of Escherichia coli under various physiological conditions.

Authors:  A L KOCH
Journal:  Ann N Y Acad Sci       Date:  1963-01-21       Impact factor: 5.691

2.  Further quantitative studies on the reaction of chlorine with bacteria in water disinfection. II. Experimental investigations with C136 and P32.

Authors:  L FRIBERG
Journal:  Acta Pathol Microbiol Scand       Date:  1957

3.  Osmotically induced volume and turbidity changes of Escherichia coli due to salts, sucrose and glycerol, with particular reference to the rapid permeation of glycerol into the cell.

Authors:  M M Alemohammad; C J Knowles
Journal:  J Gen Microbiol       Date:  1974-05

Review 4.  On the interaction between phagocytes and micro-organisms.

Authors:  P Elsbach
Journal:  N Engl J Med       Date:  1973-10-18       Impact factor: 91.245

Review 5.  Maltose and lactose transport in Escherichia coli. Examples of two different types of concentrative transport systems.

Authors:  R Hengge; W Boos
Journal:  Biochim Biophys Acta       Date:  1983-08-11

6.  Membrane H+ conductance of Streptococcus lactis.

Authors:  P C Maloney
Journal:  J Bacteriol       Date:  1979-10       Impact factor: 3.490

7.  Myeloperoxidase-hydrogen peroxide-chloride antimicrobial system: effect of exogenous amines on antibacterial action against Escherichia coli.

Authors:  E L Thomas
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

8.  Effects of phagocytosis by rabbit granulocytes on macromolecular synthesis and degradation in different species of bacteria.

Authors:  P Elsbach; P Pettis; S Beckerdite; R Franson
Journal:  J Bacteriol       Date:  1973-08       Impact factor: 3.490

9.  Properties of chick embryo chondrocytes grown in serum-free medium.

Authors:  J H Glaser; H E Conrad
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

10.  Substrate specificity and transport properties of the glycerol facilitator of Escherichia coli.

Authors:  K B Heller; E C Lin; T H Wilson
Journal:  J Bacteriol       Date:  1980-10       Impact factor: 3.490

View more
  21 in total

1.  Hypochlorous acid-promoted loss of metabolic energy in Escherichia coli.

Authors:  W C Barrette; J M Albrich; J K Hurst
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

2.  Role of extracellular iron in the action of the quinone antibiotic streptonigrin: mechanisms of killing and resistance of Neisseria gonorrhoeae.

Authors:  M S Cohen; Y Chai; B E Britigan; W McKenna; J Adams; T Svendsen; K Bean; D J Hassett; P F Sparling
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 3.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  Identification of oxidant susceptible proteins in Salmonella Typhimurium.

Authors:  Shekhar Apoorva; Pranatee Behera; Basavaraj Sajjanar; Manish Mahawar
Journal:  Mol Biol Rep       Date:  2020-02-19       Impact factor: 2.316

5.  Differential effects of myeloperoxidase-derived oxidants on Escherichia coli DNA replication.

Authors:  H Rosen; B R Michel; D R vanDevanter; J P Hughes
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 6.  What really happens in the neutrophil phagosome?

Authors:  James K Hurst
Journal:  Free Radic Biol Med       Date:  2012-05-15       Impact factor: 7.376

7.  Loss of DNA-membrane interactions and cessation of DNA synthesis in myeloperoxidase-treated Escherichia coli.

Authors:  H Rosen; J Orman; R M Rakita; B R Michel; D R VanDevanter
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Neutrophil bleaching of GFP-expressing staphylococci: probing the intraphagosomal fate of individual bacteria.

Authors:  Jamie Schwartz; Kevin G Leidal; Jon K Femling; Jerrold P Weiss; William M Nauseef
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

9.  Viability and metabolic capability are maintained by Escherichia coli, Pseudomonas aeruginosa, and Streptococcus lactis at very low adenylate energy charge.

Authors:  W C Barrette; D M Hannum; W D Wheeler; J K Hurst
Journal:  J Bacteriol       Date:  1988-08       Impact factor: 3.490

Review 10.  Bacterial responses to reactive chlorine species.

Authors:  Michael J Gray; Wei-Yun Wholey; Ursula Jakob
Journal:  Annu Rev Microbiol       Date:  2013-06-14       Impact factor: 15.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.